Disulfiram’s anticancer activity is mediated by its ability to suppress DNMT1 and through the reactivation of epigenetically silenced genes such as APC and RARB in prostate cancer cell lines (70) (Table 4, Section 1). This evidence concerns the gene DNMT1 and prostate cancer.